Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue
Standard
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue. / Knappe, Ulrich J; Hagel, Christian; Lisboa, Björn W; Wilczak, Waldemar; Lüdecke, Dieter K; Saeger, Wolfgang.
In: ACTA NEUROPATHOL, Vol. 106, No. 5, 11.2003, p. 471-8.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue
AU - Knappe, Ulrich J
AU - Hagel, Christian
AU - Lisboa, Björn W
AU - Wilczak, Waldemar
AU - Lüdecke, Dieter K
AU - Saeger, Wolfgang
PY - 2003/11
Y1 - 2003/11
N2 - Data on the dural invasiveness of pituitary adenomas have been correlated to the expression of matrix metalloproteinases (e.g. MMP-9). Serine proteases have not yet been investigated in human pituitary adenomas. In this study, paraffin-embedded material from 84 human pituitary adenomas (acromegaly n=18, Cushing's disease n=21, prolactinoma n=18, thyroid-stimulating hormone-secreting adenoma n=1, nonsecreting adenoma n=26) and 9 nontumourous anterior pituitary lobes (obtained from patients with prostate cancer) was immunohistochemically analysed for expression of MMP-2, MMP-9, tissue inhibitor of metalloproteinases-2 (TIMP-2), urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and interleukin-6 (IL-6). Cavernous sinus invasion was determined by assessment of preoperative magnetic resonance imaging and intraoperative inspection (invasive n=50, noninvasive n=34). In pituitary adenomas, reactions were positive (diffuse expression) to MMP-2 (74% of cases), MMP-9 (49%), TIMP-2 (88%), uPA (89%), uPAR (90%), tPA (69%), and PAI-1 (87%). A weak expression of IL-6 was found in 12% of the adenomas. All reactions were positive (focal expression) in every sample of anterior lobe tissue, except for uPA (negative in 3 out of 9 cases), and IL-6 (faintly positive in 5 out of 8 cases). Adenomas showed remarkably greater expression of uPA than anterior lobe tissue (Chi-square P<0.05). Nonsecreting adenomas exhibited a stronger tendency towards overexpression of uPA in invasive tumours when compared to noninvasive adenomas (Chi-square P=0.053). We found no correlation of MMP-9 expression and tumour invasion. TIMP-2 was overexpressed in noninvasive as compared to invasive adenomas (Chi-square P<0.05). The interrelationship between MMPs and serine proteinases in pituitary adenomas remains to be elucidated. From our data, a correlation between IL-6 and an activation of MMP-9 cannot be proven. The uPA-system may, however, play a role in dural invasion of pituitary adenomas.
AB - Data on the dural invasiveness of pituitary adenomas have been correlated to the expression of matrix metalloproteinases (e.g. MMP-9). Serine proteases have not yet been investigated in human pituitary adenomas. In this study, paraffin-embedded material from 84 human pituitary adenomas (acromegaly n=18, Cushing's disease n=21, prolactinoma n=18, thyroid-stimulating hormone-secreting adenoma n=1, nonsecreting adenoma n=26) and 9 nontumourous anterior pituitary lobes (obtained from patients with prostate cancer) was immunohistochemically analysed for expression of MMP-2, MMP-9, tissue inhibitor of metalloproteinases-2 (TIMP-2), urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and interleukin-6 (IL-6). Cavernous sinus invasion was determined by assessment of preoperative magnetic resonance imaging and intraoperative inspection (invasive n=50, noninvasive n=34). In pituitary adenomas, reactions were positive (diffuse expression) to MMP-2 (74% of cases), MMP-9 (49%), TIMP-2 (88%), uPA (89%), uPAR (90%), tPA (69%), and PAI-1 (87%). A weak expression of IL-6 was found in 12% of the adenomas. All reactions were positive (focal expression) in every sample of anterior lobe tissue, except for uPA (negative in 3 out of 9 cases), and IL-6 (faintly positive in 5 out of 8 cases). Adenomas showed remarkably greater expression of uPA than anterior lobe tissue (Chi-square P<0.05). Nonsecreting adenomas exhibited a stronger tendency towards overexpression of uPA in invasive tumours when compared to noninvasive adenomas (Chi-square P=0.053). We found no correlation of MMP-9 expression and tumour invasion. TIMP-2 was overexpressed in noninvasive as compared to invasive adenomas (Chi-square P<0.05). The interrelationship between MMPs and serine proteinases in pituitary adenomas remains to be elucidated. From our data, a correlation between IL-6 and an activation of MMP-9 cannot be proven. The uPA-system may, however, play a role in dural invasion of pituitary adenomas.
KW - Adenoma/enzymology
KW - Adolescent
KW - Adult
KW - Antibodies, Antinuclear/metabolism
KW - Antibodies, Monoclonal/metabolism
KW - Cell Count
KW - Female
KW - Gonadotropins, Pituitary/metabolism
KW - Humans
KW - Immunohistochemistry
KW - Interleukin-6/metabolism
KW - Ki-67 Antigen/metabolism
KW - Male
KW - Matrix Metalloproteinase 2/metabolism
KW - Matrix Metalloproteinase 9/metabolism
KW - Middle Aged
KW - Pituitary Gland, Anterior/enzymology
KW - Pituitary Neoplasms/enzymology
KW - Plasminogen Activator Inhibitor 1/metabolism
KW - Serine Endopeptidases/metabolism
KW - Tissue Inhibitor of Metalloproteinase-2/metabolism
KW - Urokinase-Type Plasminogen Activator/metabolism
U2 - 10.1007/s00401-003-0747-5
DO - 10.1007/s00401-003-0747-5
M3 - SCORING: Journal article
C2 - 12904990
VL - 106
SP - 471
EP - 478
JO - ACTA NEUROPATHOL
JF - ACTA NEUROPATHOL
SN - 0001-6322
IS - 5
ER -